Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

$99 Cash Card Program provides 3000-3800 units of any combination of Novo Nordisk analog insulins in vials or pens. NovoLog authorized generics are available at half...
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
Defining pump terms like basal rates, carb ratios, insulin sensitivity, and more
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
Using your insurance company’s website, mobile app, or direct phone number can help you price a drug based on your current insurance plan coverage benefits
As we enter hurricane season, here are three important steps people with diabetes can take to prepare for natural disasters
Lilly’s Baqsimi is a needle-free, simple treatment for severe hypoglycemia – bringing long-needed innovation to use of glucagon in emergency settings. Expected in...
What is off-label use? How to navigate conversations with your healthcare provider and limited insurance coverage
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
For now, another SGLT-2 inhibitor pill already approved for people with type 2 diabetes is not approved for people with type 1 diabetes in the US. The drug was recently...
Did your insurance or pharmacy switch your medication, without your medical professional knowing? This is called non-medical switching. Learn what you can do about it
How one clinic is integrating diabetes and heart health, focusing on comprehensive risk reduction, including medications that both lower blood glucose and protect the...
Powerful A1C-lowering from Victoza now an option for ages 10-17, in addition to metformin and insulin
A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...
A once-daily pill combining metformin, Farxiga, and Onglyza helps lower A1C and support weight loss
The first GLP-1 pill for type 2 diabetes offers weight loss and A1C reduction without injections; US decision expected in September 2019, EU decision expected spring of...
Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!

Pages